| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,230,405,536 | 993,213,672 | 883,696,971 | 870,743,003 | 753,810,593 |
| Selling, General and Administrative Expenses
|
-43,276,162 | -43,871,464 | -43,340,950 | -246,121,418 | -268,843,162 |
| Depreciation, Amortization and Depletion
|
-5,264,783 | -4,798,587 | -4,142,585 | -10,474,592 | -10,976,908 |
|
Taxes Other Than Income Taxes
|
-24,544,345 | -24,544,345 | -17,819,879 | -16,445,594 | -20,480,476 |
| Total Net Finance Income/Expense
|
-183,121 | -- | -183,121 | -200,488 | -- |
|
Amortization and Accretion of Securities
|
5,660,529 | 18,664,540 | 7,039,816 | -4,064,016 | 0 |
| Net Investment Income
|
-- | -- | -- | -- | -- |
| Irregular Income/Expenses
|
-260,684 | -- | 100,753 | 8,119,158 | 3,948,591 |
|
Pretax Income
|
119,527,193 | 93,608,818 | 20,089,658 | 68,578,074 | 105,991,095 |
|
Provision for Income Tax
|
3,287,462 | 6,165,464 | 18,590,880 | 15,997,649 | -14,852,816 |
|
Net Income from Continuing Operations
|
122,814,655 | 99,774,282 | 38,680,538 | 84,575,723 | 91,138,279 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
122,814,655 | 99,774,282 | 38,680,538 | 84,575,723 | 91,138,279 |
|
Non-Controlling/Minority Interests
|
-2,613 | -2,117 | 6,949 | 5,584 | 6,155 |
|
Net Income after Non-Controlling/Minority Interests
|
122,812,042 | 99,772,165 | 38,687,487 | 84,581,307 | 91,144,434 |
|
Net Income Available to Common Stockholders
|
122,812,042 | 99,772,165 | 38,687,487 | 84,581,307 | 91,144,434 |
|
Diluted Net Income Available to Common Stockholders
|
122,812,042 | 99,772,165 | 38,687,487 | 84,581,307 | 91,144,434 |
| Basic EPS
|
197.83 | 160.71 | 62.32 | 136.00 | 147.00 |
| Diluted EPS
|
197.83 | 160.71 | 62.32 | 136.00 | 146.82 |
|
Basic Weighted Average Shares Outstanding
|
620,806.68 | 620,806.68 | 620,806.68 | 620,806.68 | 620,806.68 |
|
Diluted Weighted Average Shares Outstanding
|
620,806.68 | 620,806.68 | 620,806.68 | 620,806.68 | 620,806.68 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
119,527,193 | 93,608,818 | 20,089,658 | 68,578,074 | 105,991,095 |
|
EBITDA
|
124,791,976 | 98,407,405 | 24,232,243 | 79,052,666 | 116,968,003 |
|
Normalized EBITDA
|
125,052,660 | 98,407,405 | 24,232,243 | 70,933,508 | 113,019,412 |
|
Normalized Income
|
123,017,988.52 | 99,774,282 | 38,680,538 | 78,242,779.76 | 87,743,015.90 |
|
Total Unusual Items
|
260,684 | 0 | 0 | -8,119,158 | -3,948,591 |
|
Total Unusual Items Excluding Goodwill
|
260,684 | 0 | 0 | -8,119,158 | -3,948,591 |
|
Tax Effect of Unusual Items
|
57,350.48 | 0 | 0 | -1,786,214.76 | -553,327.90 |
|
Tax Rate, Calculated
|
0.22 | 0.22 | 0.22 | 0.22 | 0.14 |
12/31/2022 - 10/12/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade